China Resources Sanjiu Medical & Pharmaceutical Co Ltd - Company Profile
Powered by 
All the data and insights you need on China Resources Sanjiu Medical & Pharmaceutical Co Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date China Resources Sanjiu Medical & Pharmaceutical Co Ltd Strategy Report
- Understand China Resources Sanjiu Medical & Pharmaceutical Co Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
China Resources Sanjiu Medical & Pharmaceutical Co Ltd (CR Sanjiu) a subsidiary of China Resources (Holdings) Co., Ltd. researches and develops, manufactures and commercializes pharmaceutical products including traditional Chinese medicine OTC and prescription drugs. Sanjiu’s product portfolio comprises OTC drugs, antibiotic drugs and active pharmaceutical ingredients(APIs), Chinese prescription medicines and traditional Chinese medicine (TCM) and formula granules. The company offers its products under 999 brand, and Sanjiu Weitai series among others. It also provides packaging, printing, international trade business and other services. The company has presence in China and also exports to the overseas markets. Sanjiu is headquartered in Shenzhen, China.
Headquarters
China
Address
Guanlan Hi-Tech Park, No. 1 Guanqing Road, Longhua New District, Shenzhen, Guangdong, 518110
Website
www.999.com.cn
Telephone
86 755 83360999
No of Employees
20,318
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
000999 (SHE)
Revenue (2022)
$3.5B
36.8%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
16.5%
(2022 vs 2021)
Market Cap*
$7.9B
Net Profit Margin (2022)
XYZ
-14.8%
(2022 vs 2021)
* As of and is in US$
China Resources Sanjiu Medical & Pharmaceutical Co Ltd premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| Non-prescription Drugs: | . | 999 |
| Traditional Chinese Medicine Prescription Drugs | Medical Products Distribution | Lixiwang |
| Antibiotics and Generic Drugs | Shunfeng | |
| XYZ | ||
| XYZ | ||
| XYZ |
Competitor Comparison
| Key Parameters | China Resources Sanjiu Medical & Pharmaceutical Co Ltd | Yunnan Baiyao Group Co Ltd | Jiangsu Hengrui Medicine Co Ltd | Chongqing Taiji Industry (Group) Co Ltd | Tasly Pharmaceutical Group Co Ltd |
|---|---|---|---|---|---|
| Headquarters | China | China | China | China | China |
| City | Shenzhen | Kunming | Lianyungang | Chongqing | Tianjin |
| State/Province | Guangdong | Yunnan | Jiangsu | Chongqing | Tianjin |
| No. of Employees | 20,318 | 8,834 | 20,636 | 12,589 | 9,183 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Qiu Huawei | Chairman | Executive Board | - | - |
| Zhao Bingxiang | President; Director | Executive Board | - | - |
| Zhou Hu | Vice President; Director; Secretary of the Board | Executive Board | - | - |
| Liang Zheng | Chief Financial Officer | Senior Management | - | - |
| Wu Wenduo | Vice President | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward